Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 4

Results: 12

Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer.

Published in:

2022

By:

Bose, Chinmoy K.

Publication type:

journal article

The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.

Published in:

2022

By:

Li, Jianpeng;
Cao, Jinlong;
Liang, Cheng;
Deng, Ran;
Li, Pan;
Tian, Junqiang

Publication type:

journal article

Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells.

Published in:

2022

By:

Ozel, Buket;
Kipcak, Sezgi;
Biray Avci, Cigir;
Gunduz, Cumhur;
Saydam, Guray;
Aktan, Cagdas;
Selvi Gunel, Nur

Publication type:

journal article

Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.

Published in:

2022

By:

Chen, Wanjun;
Liang, Weijie;
He, Yongjian;
Liu, Chixiang;
Chen, Hongtian;
Lv, Piao;
Yao, Yuan;
Zhou, Huayou

Publication type:

journal article

ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.

Published in:

2022

By:

He, Li;
Lv, Sinan;
Ma, Xuejiao;
Jiang, Sufang;
Zhou, Fang;
Zhang, Yunwu;
Yu, Rong;
Zhao, Yuhua

Publication type:

journal article

The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma.

Published in:

2022

By:

Goker Bagca, Bakiye;
Biray Avci, Cigir;
Sezgin, Baha;
Veral, Ali;
Gode, Sercan;
Karci, Halil Bulent

Publication type:

journal article

Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells.

Published in:

2022

By:

Zhang, Lemeng;
Cheng, Tianli;
Yang, Hua;
Chen, Jianhua;
Wen, Xiaoping;
Jiang, Zhou;
Yi, Huihuang;
Luo, Yongzhong

Publication type:

journal article

A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.

Published in:

Medical Oncology, 2022, v. 39, n. 4, p. 1, doi. 10.1007/s12032-021-01637-0

By:

Hamm, Caroline;
Fifield, Bre-Anne;
Kay, Amin;
Kulkarni, Swati;
Gupta, Rasna;
Mathews, John;
Ferraiuolo, Rosa-Maria;
Al-Wahsh, Huda;
Mailloux, Emily;
Hussein, Abdulkadir;
Porter, Lisa A.

Publication type:

Article

CDK9 inhibitors in multiple myeloma: a review of progress and perspectives.

Published in:

2022

By:

Borowczak, Jędrzej;
Szczerbowski, Krzysztof;
Ahmadi, Navid;
Szylberg, Łukasz

Publication type:

journal article

A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.

Published in:

2022

By:

Li, Xingchen;
Wan, Zhiyi;
Liu, Xiu;
Ou, Kai;
Yang, Lin

Publication type:

journal article

A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.

Published in:

2022

By:

Shirin, Marzieh;
Madadi, Sajedeh;
Peyravian, Noshad;
Pezeshkian, Zahra;
Rejali, Leili;
Hosseini, Masoumeh;
Moradi, Afshin;
Khanabadi, Binazir;
Sherkat, Ghazal;
Aghdaei, Hamid Asadzadeh;
Nazemalhosseini-Mojarad, Ehsan

Publication type:

journal article

RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression.

Published in:

Medical Oncology, 2022, v. 39, n. 4, p. 1, doi. 10.1007/s12032-021-01631-6

By:

Zhang, Yin-Ling;
Cao, Jin-Ling;
Zhang, Ye;
Liao, Li;
Deng, Ling;
Yang, Shao-Ying;
Hu, Shu-Yuan;
Ning, Yan;
Zhang, Fang-Lin;
Li, Da-Qiang

Publication type:

Article